BOYANOV & Co. advised J.P. Morgan and Wilmington Trust on the accession of a Bulgarian subsidiary of Alvogen in two facility agreements
BOYANOV & Co. advised J.P. Morgan and Wilmington Trust in their capacity as Agent and Security Agent in relation to the accession of the Bulgarian entity Alvogen Pharma Trading Europe EOOD as additional guarantor to loan agreements of a total amount of more than EUR 2 bln. The company is part of the Alvogen group – a global privately owned pharmaceutical company focused on developing, manufacturing, and selling generic, brand, over-the-counter (OTC), and biosimilar products for patients around the world, whose CEE business was acquired in 2019 by Zentiva.
BOYANOV & Co. advised the Agent and the Security Agent in relation to the entry of the Bulgarian subsidiary into a senior facility agreement and a second lien facility agreement as a guarantor and the Bulgarian law-related security.
The accession was completed on 24 August 2021.